ImmunoCellular Therapeutics Ltd (IMUC PINK) stock market data APIs
$0.1401
0(0%)
as of February 6, 2026
Try our APIs with
free plan!
ImmunoCellular Therapeutics Ltd Financial Data Overview
Price chart is built with
Anychart
EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company's lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey.
Prev. Close
0.1401
Open
0.1401
High
0.1401
Low
0.1401
52 wk Range
0.036-0.218
Market Cap
13 915 K
P/E Ratio
0.0141
Shares Outstanding
127 M
EPS
0
Beta
1.179
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ImmunoCellular Therapeutics Ltd data using free add-ons & libraries
Get ImmunoCellular Therapeutics Ltd Fundamental Data
ImmunoCellular Therapeutics Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -6 072 270
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-20
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ImmunoCellular Therapeutics Ltd News
New
Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors
Codexis, Inc. REDWOOD CITY, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced the...
ImmunoCellular Therapeutics: Notice of Proposed Settlement of Derivative Action
LOS ANGELES, Aug. 09, 2019 (GLOBE NEWSWIRE) -- ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (OTC: IMUC), today issued the following announcement. The following is being released pursuan...
New Research Coverage Highlights K12, ImmunoCellular Therapeutics, The First of Long Island, Blue Bird, The Providence Service, and German American — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders,...
Research Report Identifies Gastar Exploration, Monroe Capital, SandRidge Energy, ImmunoCellular Therapeutics, Inseego, and Digital Turbine with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, ...
Get ImmunoCellular Therapeutics Ltd fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
